Parenteral antibiotics for the treatment of serious neonatal bacterial infections in developing country settings

Gary L Darmstadt1, Maneesh Batra, Anita K M Zaidi

  • 1Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Gary.Darmstadt@gatesfoundation.org

Insights

Selecting effective antimicrobial regimens for neonatal sepsis in developing countries requires careful consideration of safety and cost. Procaine penicillin G with gentamicin or ceftriaxone are recommended for community-based treatment.

Area of Science:

  • Neonatal infectious diseases
  • Pharmacology of antimicrobial agents
  • Global health challenges

Background:

  • Neonatal sepsis management in developing countries presents unique challenges.
  • Selection of antimicrobial regimens must balance efficacy, safety, simplicity, and cost.
  • Community settings require specific considerations for treatment protocols.

Purpose of the Study:

  • To review pharmacologic profiles of parenteral antibiotics for neonatal infections.
  • To identify suitable antimicrobial regimens for developing country community settings.
  • To evaluate antibiotic properties relevant to extended-interval, intramuscular dosing.

Main Methods:

  • Systematic review of available data on parenteral antibiotic pharmacologic profiles.
  • Focus on properties pertinent to neonatal infections in resource-limited communities.
  • Analysis of efficacy, safety, and dosing characteristics.

Main Results:

  • Extended-interval, intramuscular dosing regimens offer attractive properties for community-based neonatal infection management.
  • Penicillins and cephalosporins demonstrate favorable efficacy and safety.
  • Aminoglycosides are safe and effective with appropriate use, despite narrow therapeutic indices.
  • Chloramphenicol is least preferred due to potential for severe toxicity.

Conclusions:

  • Procaine penicillin G combined with gentamicin is a preferred parenteral regimen.
  • Ceftriaxone monotherapy is another preferred option.
  • These regimens are safe and effective with extended intramuscular intervals (≥24 hours) for community and first-level facility use.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...